The Spanish Ministry of Health's soon-to-be-inaugurated foundationdedicated to research into the prevention of AIDS, is to be entirely funded by the five major drug companies marketing treatments against the disease in Spain, according to Cinco Dias.
Roche, Glaxo Wellcome, Bristol-Myers Squibb, Merck, Sharp & Dohme and Abbott Laboratories will each contribute 100 million pesetas ($68.4 million) to the foundation, which will finance research grants into the disease. It is hoped that the venture will be operational before the end of the year. Cinco Dias notes that the five companies have been privately critical of the measure as the Ministry will have total control over the administration of the fund.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze